Product Name :
Lesinurad
Description:
Lesinurad, also known as RDEA594, is a selective uric acid re-absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body. RDEA594 has been shown to normalize the amount of uric acid excreted by gout patients previously classified as under-excretors. Lesinurad received FDA approval on December 22, 2015.
CAS:
878672-00-5
Molecular Weight:
404.28
Formula:
C17H14BrN3O2S
Chemical Name:
2-{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid
Smiles :
OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=CC=CC=C12
InChiKey:
FGQFOYHRJSUHMR-UHFFFAOYSA-N
InChi :
InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Lesinurad, also known as RDEA594, is a selective uric acid re-absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body. RDEA594 has been shown to normalize the amount of uric acid excreted by gout patients previously classified as under-excretors. Lesinurad received FDA approval on December 22, 2015.|Product information|CAS Number: 878672-00-5|Molecular Weight: 404.28|Formula: C17H14BrN3O2S|Chemical Name: 2-{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid|Smiles: OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=CC=CC=C12|InChiKey: FGQFOYHRJSUHMR-UHFFFAOYSA-N|InChi: InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Eribulin} MedChemExpress|{Eribulin} ADC Cytotoxin|{Eribulin} Biological Activity|{Eribulin} Data Sheet|{Eribulin} supplier|{Eribulin} Cancer} |Shelf Life: ≥360 days if stored properly.{{Vilazodone} site|{Vilazodone} GPCR/G Protein|{Vilazodone} Protocol|{Vilazodone} In Vitro|{Vilazodone} supplier|{Vilazodone} Epigenetic Reader Domain} |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:27108903 |Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|